Literature DB >> 9074427

Ultrastructural analysis of the distribution of the vitronectin receptor (alpha v beta 3) in human platelets and megakaryocytes reveals an intracellular pool and labelling of the alpha-granule membrane.

C Poujol1, A T Nurden, P Nurden.   

Abstract

The vitronectin receptor (VnR or alpha v beta 3) belongs to the cytoadhesin subclass of the integrin family. This subclass consists of two receptors which have the beta 3 subunit in common: GP IIb-IIIa complexes (or alpha IIb beta 3) and VnR. We report the subcellular distribution of VnR within human platelets as determined by immunogold staining of ultrathin frozen sections and transmission electron microscopy. Monoclonal antibodies directed against: (i) the alpha v subunit (LM142, AMF7, CLB-706), or (ii) an epitope specific to the complex (LM609) were used. Although VnR is present on platelets, it is a minor component. We therefore first compared several different staining procedures to detect this integrin. Optimal localization of VnR was obtained using a multistep procedure in which biotinylated anti-mouse IgG and a monoclonal anti-biotin antibody provided staining enhancement. Results showed that although present on the surface, alpha v beta 3 was mostly detected in internal membrane systems including those of alpha-granules. Occasionally, platelet sections showed special vesicular structures covered by gold particles. These were often localized at the edge or immediately under the plasma membrane and their origin remains unclear. An internal pool of alpha v beta 3 was confirmed by flow cytometry and by using platelets from a patient with type I Glanzmann's thrombasthenia arising from a GP IIb gene defect. We also investigated the presence of VnR in megakaryocytes (MK) obtained from normal human bone marrow. A fluorescence study showed VnR in small MK with unilobulated nuclei, suggesting that synthesis of this integrin occurs early during megakaryocytopoiesis. In mature cells, VnR expression had decreased relative to GP IIb-IIIa, although intracellular staining was present in EM and alpha-granules were again labelled.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9074427     DOI: 10.1046/j.1365-2141.1997.d01-2109.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  6 in total

1.  RGDfK-functionalized gold nanorods bind only to activated platelets.

Authors:  Krystin Zeller Meidell; Ryan Robinson; Adriana Vieira-de-Abreu; Adam J Gormley; Hamidreza Ghandehari; David W Grainger; Robert A Campbell
Journal:  J Biomed Mater Res A       Date:  2016-10-11       Impact factor: 4.396

2.  In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant.

Authors:  V Combes; A C Simon; G E Grau; D Arnoux; L Camoin; F Sabatier; M Mutin; M Sanmarco; J Sampol; F Dignat-George
Journal:  J Clin Invest       Date:  1999-07       Impact factor: 14.808

Review 3.  Integrins and their role in megakaryocyte development and function.

Authors:  Xiaosheng Yang; Shlok V Chitalia; Shinobu Matsuura; Katya Ravid
Journal:  Exp Hematol       Date:  2021-12-12       Impact factor: 3.249

Review 4.  Glanzmann thrombasthenia: state of the art and future directions.

Authors:  Alan T Nurden; Xavier Pillois; David A Wilcox
Journal:  Semin Thromb Hemost       Date:  2013-08-08       Impact factor: 4.180

5.  Deep Vein Thrombosis, Raynaud's Phenomenon, and Prinzmetal Angina in a Patient with Glanzmann Thrombasthenia.

Authors:  Alan Nurden; Patrick Mercié; Pascal Zely; Paquita Nurden
Journal:  Case Rep Hematol       Date:  2012-12-31

6.  Molecular dynamics analysis of a novel β3 Pro189Ser mutation in a patient with glanzmann thrombasthenia differentially affecting αIIbβ3 and αvβ3 expression.

Authors:  Michel Laguerre; Essa Sabi; Martina Daly; Jacqueline Stockley; Paquita Nurden; Xavier Pillois; Alan T Nurden
Journal:  PLoS One       Date:  2013-11-13       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.